Buy a Home Healthcare Agency in Washington, DC

The DC Home Healthcare Market

Washington, DC sits at the intersection of an aging population and one of the highest median incomes in the country at $106,287. That combination drives consistent, above-average demand for in-home care services.

DC's healthcare workforce is dense, which helps with staffing, but it also means competition for qualified aides is real. Agencies with trained, credentialed staff on payroll are worth more than those operating with a thin roster of contractors.

The DC market is also heavily Medicaid-dependent. The District's Medicaid waiver programs, including the Community Health Administration (CHA), are a primary revenue driver for most local agencies. Buyers need to understand how much of the revenue flows through these programs and what the reimbursement rates look like going forward.

Deal Economics

At the median, you are looking at a $980,000 asking price against $282,518 in annual cash flow. That is a 3.3x multiple, which sits squarely in the SBA sweet spot.

Listings in this market span a wide range, from $120,000 on the low end to $31,000,000 at the top. The low end typically represents smaller agencies with thin revenue, limited contracts, or regulatory issues. The high end represents multi-location operators with diversified payer mixes. Most SBA-eligible transactions will fall in the $500K to $5M range.

A rough deal model at the median looks like this:

• Asking price: $980,000
• Annual cash flow: $282,518
• Implied multiple: 3.3x
• SBA loan (80%): $784,000
• Seller note (10%, full standby at 0% interest): $98,000
• Buyer cash (5%): $49,000
• Estimated annual debt service: approximately $95,000 to $105,000 (based on current SBA rates of roughly 10% to 11%, 10-year term)
• Estimated DSCR: approximately 2.7x to 3.0x

That DSCR is healthy. You have room for one bad quarter without falling below the 1.5x floor.

These are rough estimates based on market data. Actual terms depend on individual qualification and lender.

How SBA Financing Works for This Acquisition

SBA 7(a) is the standard financing vehicle for home healthcare acquisitions in this price range. The program works well here because these agencies carry real cash flow, limited hard assets, and are classified as eligible small businesses.

The equity injection is 10% of the acquisition price, not a traditional down payment. Regalis structures this as 5% buyer cash and 5% seller note on full standby, meaning the seller receives no payments on that note during the SBA loan term. We achieve full standby seller notes on more than 90% of our deals.

One flag to watch: SBA lenders scrutinize healthcare businesses more carefully than most. Expect deeper due diligence on licensing, any CMS certification, billing compliance history, and any past audits or overpayment demands from Medicaid. These are not deal-killers if handled correctly, but surprises at the lender review stage can kill timelines.

What to Look for When Evaluating an Agency

Not all cash flow in home healthcare is created equal. Here is what separates a clean deal from a problem you are inheriting.

Payer mix. Private pay and long-term care insurance revenue is more stable and better margined than Medicaid. A mix heavily skewed toward Medicaid creates reimbursement rate risk. Understand the breakdown before you model anything.

Billing compliance. Medicaid and Medicare billing errors, even accidental ones, can trigger recoupment demands years after the fact. Request a full billing audit history and ask whether the agency has received any demand letters from payers.

Caregiver turnover. Home healthcare has notoriously high turnover. Get the trailing 12-month turnover rate. Anything above 60% is a red flag and will compress cash flow post-close as you rebuild the roster.

DC licensing. Agencies operating in DC need a Home Care Agency license from the DC Department of Health. Confirm it is current, transferable, and has no pending violations. The license transfer process can add time to close.

Client concentration. If 30% or more of revenue comes from a single referral source, a hospital discharge planner, a specific senior community, or one care coordinator, that is a concentration risk worth pricing into the deal.

Frequently Asked Questions

How much does it cost to buy a home healthcare agency in Washington, DC?

The median asking price is $980,000, though listings range from $120,000 to $31,000,000. Most SBA-eligible transactions fall between $500,000 and $5,000,000. Smaller agencies under $300,000 often have thin revenue or regulatory issues that require careful diligence.

Can I use SBA financing to buy a home healthcare agency in DC?

Yes. SBA 7(a) is the standard financing vehicle for home healthcare acquisitions. The program requires a 10% equity injection, typically structured as 5% buyer cash and a 5% seller note on full standby at 0% interest. Lenders will conduct deeper-than-average due diligence given the healthcare classification.

What is the typical cash flow for a home healthcare agency in Washington, DC?

The median cash flow is $282,518 annually based on national listing data. That figure is pre-debt service. At a 3.3x median multiple, a well-structured SBA acquisition at the median price produces an estimated DSCR of 2.7x to 3.0x based on current rates.

What does a DC home healthcare agency license transfer involve?

The acquiring entity must apply for a new license with the DC Department of Health or complete an ownership change notification, depending on the transaction structure. The process can take several weeks and should be factored into your closing timeline. Confirm the current license has no pending violations before signing a letter of intent.

What payer mix should I target when buying a DC home healthcare agency?

A healthier mix leans toward private pay and long-term care insurance rather than Medicaid. DC agencies often have significant Medicaid exposure due to the District's waiver programs, which creates reimbursement rate risk. Agencies with 40% or more private pay revenue typically command better margins and more predictable cash flow.

Talk to Regalis Capital About DC Home Healthcare Acquisitions

Home healthcare in DC is a real business with real cash flow, but the licensing, billing compliance, and Medicaid concentration issues require someone who has done this before.

Regalis Capital's deal team reviews 120 to 150 deals per week. We help buyers find, evaluate, structure, and finance acquisitions like this one from start to close. If you are seriously considering buying a home healthcare agency in Washington, DC, start with a deal assessment.

Schedule a free deal assessment with Regalis Capital